AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Infoglim M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Vats Biotech Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Infoglim M 2mg/500mg Tablet SR

Diabetic patients with type 2 mellitus may find relief with the dual-action medication, Infoglim M 2mg/500mg SR tablets. This anti-diabetic formulation combines two active components to effectively manage blood glucose levels in adults. Administer this medication orally with meals, consistently at the same time daily for optimal results. Dosage adjustments will be determined by your physician based on your individual response and blood sugar monitoring. Continuous use is crucial, even with well-controlled blood sugar, as discontinuation without medical advice risks elevated glucose levels, potentially leading to complications including renal impairment, vision loss, neuropathy, and limb loss. This medication is a cornerstone of a comprehensive diabetes management plan, complementing a balanced diet, regular physical activity, and weight management as prescribed by your doctor. Your lifestyle choices play a pivotal role in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect. Familiarize yourself with its symptoms—sweating, lightheadedness, headache, tremors—and appropriate countermeasures. Maintain regular mealtimes and always carry readily available glucose sources, such as sweets or juice. Alcohol consumption elevates hypoglycemia risk and should be minimized. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal dysfunction. Prior heart conditions should be disclosed to your physician before commencing treatment, as it may be unsuitable. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Infoglim M 2mg/500mg Tablet SR

No text provided to rephrase.

Uses of Infoglim M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Infoglim M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Infoglim M 2mg/500mg Tablet SR should be swallowed whole with food; do not break, crush, or chew it.

Common Side effects of Infoglim M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Infoglim M 2mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Infoglim M 2mg/500mg Extended-Release Tablets should be administered with a meal.

How Infoglim M 2mg/500mg Tablet SR works:

Infoglim M SR tablets (2mg/500mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Infoglim M 2mg/500mg SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Infoglim M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Sustained-release Infoglim M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Infoglim M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment. Consult your physician.

LiverLiverCAUTION

Patients with liver impairment should use Infoglim M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically recommended for individuals with mild to moderate liver disease; however, the medication is contraindicated in those with severe liver dysfunction.

What if you forget to take Infoglim M 2mg/500mg Tablet SR :

Should you forget a dose of Infoglim M 2mg/500mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Infoglim M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Infoglim M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Infoglim M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Infoglim M 2mg/500mg Tablet SR and seek immediate medical attention.
Infoglim M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Infoglim M 2mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Infoglim M 2mg/500mg Tablet SR can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Infoglim M 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Infoglim M 2mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Infoglim M 2mg/500mg Tabl...
58
MRP 67
13% off